World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
37377
World Ranking
8576
National Ranking
4417

Overview

Victor G. Prieto is affiliated with The University of Texas MD Anderson Cancer Center in the United States and has a primary research focus within the field of Medicine. Their work encompasses a range of subfields including Oncology, Dermatology, Molecular Biology, Epidemiology, and Immunology. Over 260 publications contribute to these areas of study.

The research topics covered by Victor G. Prieto include:

  • Cutaneous Melanoma Detection and Management
  • Cutaneous lymphoproliferative disorders research
  • Cancer and Skin Lesions
  • CAR-T cell therapy research
  • Melanoma and MAPK Pathways
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses

Several recent papers illustrate the scope of Prieto's research output. These include:

  • Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma, 2023, New England Journal of Medicine
  • Neoadjuvant relatlimab and nivolumab in resectable melanoma, 2022, Nature
  • TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer, 2020, Modern Pathology
  • Factors Influencing US Allopathic Medical Students to Choose Pathology as a Specialty, 2020, Academic Pathology
  • Transition From a Standard to a Hybrid On-Site and Remote Anatomic Pathology Training Model During the Coronavirus Disease 2019 (COVID-19) Pandemic, 2020, Archives of Pathology & Laboratory Medicine

Victor G. Prieto frequently collaborates with a consistent group of co-authors, reflecting established research partnerships. These include Phyu P. Aung, Carlos A. Torres-Cabala, Jonathan L. Curry, Priyadharsini Nagarajan, and Woo Cheal Cho.

Publication venues where Victor G. Prieto has contributed multiple articles include:

  • Journal of Cutaneous Pathology
  • American Journal of Dermatopathology
  • Archives of Pathology & Laboratory Medicine
  • Academic Pathology
  • Laboratory Investigation

Best Publications

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.

    Pei Ling Chen;Whijae Roh;Alexandre Reuben;Zachary A. Cooper

  • Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

    Whijae Roh;Pei Ling Chen;Alexandre Reuben;Christine N. Spencer

  • Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    Rodabe N. Amaria;Sangeetha M. Reddy;Hussein A. Tawbi;Michael A. Davies

  • Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

    Howard M. Shulman;David Kleiner;Stephanie J. Lee;Thomas Morton

  • Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

    Laszlo G. Radvanyi;Chantale Bernatchez;Minying Zhang;Patricia S. Fox

  • Mortality Risk From Squamous Cell Skin Cancer

    Gary L. Clayman;J. Jack Lee;F. Christopher Holsinger;Xian Zhou

  • A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

    Lei L. Chen;Jonathan C. Trent;Elsie F. Wu;Gregory N. Fuller

  • Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy.

    Ken Wyman;Michael B. Atkins;Victor Prieto;Omar Eton

  • Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation.

    Brian J. Dillon;Victor G. Prieto M.D.;Steven A. Curley;C. Mark Ensor

  • A novel AKT3 mutation in melanoma tumours and cell lines

    Michael A Davies;K. Stemke-Hale;C. Tellez;T. L. Calderone

  • Lymph Node Metastases from Cutaneous Squamous Cell Carcinoma of the Head and Neck

    Brian A. Moore;Randal S. Weber;Victor Prieto;Adel El-Naggar

  • Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma

    Julie A. Ellerhorst;Victoria R. Greene;Suhendan Ekmekcioglu;Carla L. Warneke

  • Reduction of adhesions with composite AlloDerm/polypropylene mesh implants for abdominal wall reconstruction.

    Charles E. Butler;Victor G. Prieto

  • Phase II trial of imatinib mesylate in patients with metastatic melanoma

    K B Kim;O Eton;D W Davis;M L Frazier

  • NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

    Howard M. Shulman;Diana M. Cardona;Joel K. Greenson;Sangeeta Hingorani;Sangeeta Hingorani;Sangeeta Hingorani

  • Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays

    Kayuri U. Patel;Sara S. Szabo;Vivian S. Hernandez;Victor G. Prieto

  • Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma

    Michael A. Davies;Katherine Stemke-Hale;E. Lin;Carmen Tellez

  • An exploratory investigation of the morphology and biochemistry of cellulite

    Michael Rosenbaum;Victor Prieto;Johan Hellmer;Michael Boschmann

  • Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With Melanoma

    Jeffrey E. Gershenwald;Robert H.I. Andtbacka;Victor G. Prieto;Marcella M. Johnson

Frequent Co-Authors

Madeleine Duvic
Madeleine Duvic The University of Texas MD Anderson Cancer Center
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center
Merrick I. Ross
Merrick I. Ross The University of Texas MD Anderson Cancer Center
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Michael A. Davies
Michael A. Davies The University of Texas MD Anderson Cancer Center
Bita Esmaeli
Bita Esmaeli The University of Texas MD Anderson Cancer Center
Elizabeth A. Grimm
Elizabeth A. Grimm The University of Texas MD Anderson Cancer Center
Jennifer A. Wargo
Jennifer A. Wargo The University of Texas MD Anderson Cancer Center
Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens the door to a variety of related online degree programs and advancement opportunities. Many students consider fields connected to healthcare or wish to enhance their credentials online. For example, you can choose from a variety of online nutritionist degree options to specialize in food science and wellness.

If you're interested in healthcare leadership, the best mha programs offer accredited online pathways to earn a Master's in Healthcare Administration. For registered nurses aiming to further their careers quickly, there are reputable rn to bsn online without clinicals programs which allow RNs to earn their bachelor's without on-site requirements.

For those seeking advanced nursing practice, the fastest online dnp programs can help experienced nurses gain a Doctor of Nursing Practice degree faster and more flexibly. Exploring these options can help you find the best pathway for your career goals within the broad field of medicine.

Best Scientists Citing Victor G. Prieto

Trending Scientists